Category Archives: Research

Dr.KSR Prasad Presentations

Ayurmitra Dr.KSR Prasad at http://www.technoayurveda.com 

On request all Presentations and Papers by Ayurmitra Dr. KSR Prasad is pooled here. Follow Technoayurveda Ayurmitra Dr.KSR Prasad on Slideshare

  1. Ayurveda Atyayika Chikitsa
  2. Avenues for Research & updates in Ayurveda
  3. Opportunities & Obstacles in Ayurveda
  4. Unveiled Scientific Facts of Ayurveda
  5. Chikitsa Interpretation of Agni
  6. Clinical importance of Pittadhara Kala
  7. Ambrosia for Youthful Longevity
  8. Vajikarana & Sexology
  9. Rasaaushadhi In Geriatric / Aphrodisiac Practice
  10. Vajikarana – The Ancient Semen Farming, (Eugenics) / Sexology
  11. Application of Vajikarana & Rasayana in clinical practice -2009
  12. Science and technologies of Samsodhana karma
  13. Validation of Vasti for futurity
  14. Aushadha Sevana (Applied Medicinal Intake)
  15. Ayurveda Today for Managing Tomorrow
  16. Ayurveda Nutriceuticals in Genitourinary Tract disorders or Mirror
  17. Excellence of Rasaaushadhi In Ayurveda Practice1
  18. Excellence of Rasaaushadhi In Ayurveda Practice2
  19. Madhumeha (Diabetes) Management
  20. Impotency – A Birds Eye View
  21. AETIOPATHOLOGY OF MADHUMEHA
  22. Bhutagni in Liver 
  23. Impregnable mind in somatic pathology
  24. Management of Pranavaha srotas Diseases “Ayurvedic Pulmonology”
  25. Anaemia Control through Ayurveda
  26. Conceptual study of Mootravaha Srotas
  27. Beautake- A Symposia on cosmetology
  28. Gender Specific diseases of Ayurveda W.S.R. to Male Erectile Dysfunction
  29. Abhyanga – An external Oilation therapy – (MASSAGE)
  30. ROLE OF AYURVEDIC SYSTEM OF MEDICINE IN AIDS
  31. APPRAISAL OF VAMANA – AN ENDOTOXIN EXPULSION THERAPY
  32. Vamana – A scientific approach
  33. Dhanyamla Bahiparimarjana
  34. Scenario of Panchakarma standardization
  35. Rakta Pittam
  36. Identifying and managing “Manyasthambha” (Cervical spondylarthritis)
  37. Uttara Vasti in Male – A scientific approach
  38. Moordhni Taila chikitsa
  39. Introduction to Kshudra Kusta (11) & Vicharchika with its management
  40. Terminology of Kayachikitsa
  41. VASTI IN DIFFERENT PARTS OF BODY KATI VASTI AND UROVASTI
  42. Jara Shastra::A study of Dhatupaka
  43. Avrutavata and its Chikitsa
  44. Issues of Neuro ageing -Text
  45. Issues of Neuro ageing -PPT
  46. Encrypted Ayurveda to Decrypted Evidence-txt
  47. Phytonomy-Plant Anatomy
  48. Wow Breast Oh Bra 4 U
  49. Pumsavana – Choice of child 
  50. Clean off Madhumeha vis-à-vis Diabetes with Sadabahar  / Vinca rosea
  51. Queen of Herbs – ASPARAGUS (Shatavari) as Multi target Drug

Astrology – Jyotisham / Others

  1. Vaidya Jyotisham – AstroMedicine
  2. Quest for Key in Astro-Medicine
  3. Astrology Utility in Patient Care
  4. Result of Quest
  5. The Message form Water
  6. yoga templets 

Periodical Publication
Amruta Bindu Issue-01 Issue-02  Issue-03 Issue-04 Issue-05 Issue-06&07 Issue-08 & 09   Issue-10 & 11 (10&11mirror)
Amrita Chikitsa Vani - Jan 2009 - Feb2009

Clean off Madhumeha vis-à-vis Diabetes with Sadabahar

Ayurveda classified a Sweet disease in the Urinary syndrome of Prameha along with 20 more conditions. The precursor of this Madhumeha were told as the Obesity i.e. Sthoulya. As stated by Charaka – “Urbanization is the root cause of all diseases”, the civilized stress has its role in causing the metabolic disturbances resultant into an out come of Sweet Urine – “Diabetes”.

Diabetes usually found in the Dental clinics or examined specifically with a Family history. The phases of Madumeha are wide and its treatment more or less is regulation of stress and food habits.

Stage-1/ Agni disturbances: Disturbances of the oral hygiene and getting foul smell refer to the poor digestion and the formation of Ama in the body. Along with foul smell he may even get the referral symptoms of heaviness of body, salivation, over weight, belching, bloating, problems of teeth, pain in abdomen, etc. . . . . [Read more]

Research in Ayurveda

Rama JayasundarF∗, 6/4, Varsha Apartments, United India Colony, II Cross Street,Kodambakkam, Chennai-600 024
Email: ramajayasundar@hotmail.com

Not withstanding the fact that there is an increased interest in the Ayurvedic system of medicine throughout the world, a series of questions are being raised regarding the scientific basis of the system, standardization of its medicines, the ability of Ayurvedic physicians to talk the language of current day scientists and the doctors trained in western medicine etc. Terms such as scientific rigour, objectivity, scientific evaluation, transparency, rational approach and clinical trials are used in almost all the meetings on traditional medicinal systems. A tremendous amount of national and international funding is available for research in traditional medicines. There are a number of groups –- allopathic doctors, chemists, biochemists, pharmacologists, engineers, biologists etc. – availing these funds and working on various aspects of scientific validation and standardization of Ayurvedic treatment and
drugs. Considering the fact that Ayurveda understands the human body and treats diseases from a perspective different to that of western science, one has to look very carefully at the question of scientific
validation and extreme care has to be taken to choose the appropriate experimental and clinical models. In this complex scenario, the challenge lies in setting the standards and addressing the right questions. If done with ingenuity, the results can be very rewarding. Does the current scenario in Ayurvedic research address the above concerns? This aspect will be discussed in this paper. [download]

Biostatistical Approach to Ayurveda: Quantifying the Tridosha

A Biostatistical Approach to Ayurveda: Quantifying the Tridosha by RAJANI R. JOSHI, Ph.D., To compute quantitative estimates of the tridosha—the qualitative characterization that constitutes the core of diagnosis and treatment in Ayurveda—to provide a basis for biostatistical analysis of this ancient Indian science, which is a promising field of alternative medicine.

Birth Gender Chart

Plagiarism

Heidi Williams, “Plagiarism (Issues That Concern You)”
Greenhaven Press | 2008 | ISBN: 0737740728 | 104 pages | PDF | 2,3 MB

The 12 essays in this volume, all reprinted from other sources, look at the issue from a variety of perspectives and discuss some of the many ways that institutions are combating the problem. A common theme of many of the writings is that the Internet, and access to countless sources of information, has made copying or buying another’s work easier than ever before. While none of the writers offers up a simple solution, many examine the myriad ways of dealing with plagiarism, both proactive and reactive, including more stringent honor codes, further education, and the use of online subscriptions to companies like Turnitin.com that identify plagiarized work. Unfortunately, the selections are uneven in both quality and value, and range from the mundane to the provocative. Two standouts include John F. Kavanaugh’s “Emphasizing Personal Integrity Will Prevent Plagiarism” and Michael Thompson’s “Most Plagiarism Is Not Easy to Detect.” Accompanying photographs add little to the overall quality of the book, and the graphs and statistics are generally more confusing than edifying. Teachers and librarians will find several of the writings useful as discussion starters, thus making this a good addition for libraries looking to beef up their selections on the topic.—Jody Kopple, Shady Hill School, Cambridge, MA

Bacchieri Fundamentals of Clinical Research

Statistical methodology is an essential component of clinical (and biological) research. Therefore it is not surprising that many textbooks aiming at “explaining” statistical methods to researchers have been published and continue to appear in print. The complexity of the basic issue, that of communication between . . . . Therefore, I do hope that this book will have the fortune it deserves and that it will stimulate many bright minds to reflect further on important aspects of the methodology of research. . . . However, it is important to point out that the succession of phases, as well as the content of each phase, are flexible and change from project to project. As the clinical experimentation proceeds and the degree of certainty . . . [more]

Clinical Research – It’s great! Oops No It Isn’t

The truth is, few people know the first thing about clinical research. The public reads about a medical research project that announces unbelievable results for a miraculous drug. Some years later, another investigation completely wipes out those initial favorable findings. . . . Researchers using human beings as subjects have distinct choices as to how they will plan and organize their research. They can just observe people, or review medical records or conduct clinical trials. The four primary options for medical research . . .[more]

Statistics Is Unscientific! (Well, as Clinicians see it, anyway)

I once read a letter to the editor in which the correspondent, a clinician, described a paper’s statistical analysis as “not strictly kosher.” This might well be true, on the grounds that the statistician involved had probably not been certified by the appropriate rabbinic authorities. Leaving aside . . . So, no, the t-test was not inscribed on the stone tablets Moses brought down from Mount Sinai along with the commandment “Thou shalt not use with skewed data.” The t-test was [more]

Advances in Botanical Research

Jean-Claude Kader, Michel Delseny “Advances in Botanical Research, Volume 46″
Academic Press | 2007-12-13 | ISBN: 0123737052 | 256 pages | PDF | 2,8 Mb
Jean-Claude Kader “Advances in Botanical Research: Volume 50, 1st Edition”
Academic Press | 2009-04-15 | ISBN: 0123748355 | Pages: 272 | PDF | 1.86 MB

AAMRA vol2 Issue3

[click here]

Maori have very little joint disease!

Doctors stunned to find why New Zealand Maori have very little joint diseaseJoint Pain
Imagine if you didn’t need pain relievers every day? The Health Sciences Institute has uncovered something totally new—a completely safe and natural food extract that may be the most powerful antiinflammatory compound ever discovered. It’s called Lyprinol, an active lipid fraction isolated from the New Zealand green-lipped mussel, or Perna canaliculus. According to centuries-old tradition, native Maoris believe that eating the greenlipped mussel leads to a long and healthy life. And, in fact, medical statistics show that arthritis and rheumatic disorders are unknown among the coastal-dwelling Maori.
Scientists have now determined that the antiarthritic properties of the green-lipped mussel are due to the unique configuration of certain polyunsaturated fatty acids (or PUFAs) called Eicosatetraenoic Acids (ETAs). Related to the Omega-3 fatty acids found in fish, flaxseed, and perilla oil, ETAs display more intense and targeted antiinflammatory and anti-arthritic activity than any other known PUFA or Omega-3 fatty acid.
Research in the 1970s and 1980s confirmed that something in the New Zealand green-lipped mussel had the ability to erase arthritic pain and stiffness. A double-blind, placebo-controlled trial conducted in 1980 at the Victoria Hospital in Glasgow, England, tested a powdered mussel supplement on 66 arthritis patients.1 At the start of the six-month trial, all of the subjects had failed to respond to conventional treatment and were scheduled for surgery to repair badly damaged joints. At the close of the trial, the researchers reported improvements in 68 percent of the rheumatoid arthritis (RA) patients and in 39 percent of the osteoarthritis (OA) patients. The scientists also noted the low incidence of adverse side effects. Nearly two decades later scientists perfect the solution For the next 18 years, leading scientists from universities and research labs in Australia, Japan, and France worked together to understand the secret locked within the green-lipped mussel. Step by incremental step, the scientists managed to identify the active biological fraction of the green-lipped mussel, isolate it without destroying its essential properties, cleanse it of impurities, stabilize it, and standardize its potency for reliable results.
At every step of the way, clinical and laboratory studies confirmed that scientists were moving in the right direction. Their excitement mounted as each phase yielded a more potent and powerful compound. Even early versions of the green-lipped mussel extracts were found to be more effective than aspirin and ibuprofen in reducing inflammation. But inflammation isn’t the only thing it helped. In 1986, a trial of 53 RA patients, conducted by the Societé Française de Biologic et Dietique (SFBD) in Dijon, France, found that the greenlipped mussel extract reduced pain by 62 percent after six months, while those on a placebo had a 20 percent increase in pain.2 Lyprinol: 200 times more effective than high potency fish oil in controlling swelling Ultimately, scientists zeroed in on the ETAs in the green-lipped mussel as the active ingredients responsible for its remarkable anti-arthritic effects. This specific grouping of ETAs is not found in any other known substance. The methods used to concentrate these active components in a pure and stable form have been granted patents in several countries. The final result is now available as Lyprinol.
Researchers at the University of Queensland in Brisbane, Australia, studied the efficacy of Lyprinol using laboratory animals with adjuvant-induced polyarthritis, which is the closest model for rheumatoid arthritis in humans.3When administered as an oral supplement, Lyprinol reduced arthritis-related swelling in the animal’s paws by more than 90 percent. It was also effective when rubbed directly into the affected area. Comparisons of Lyprinol to other natural lipids, or fatty acids, known to be helpful in treating arthritis and inflammation, tested Lyprinol against flax oil, evening primrose oil, Norwegian salmon oil, and MaxEPA (a high potency fish oil product). Of these, Lyprinol was the most effective in preventing arthritis-related swelling, reducing swelling by 79 percent. MaxEPA was the next best at 50 percent.
However, the real story is the 11 dosages used to achieve these results. Achieving a 50 percent effectiveness rate required a dosage of 2000 mg/kg body weight of MaxEPA. But the effective dosage of Lyprinol was only 20 mg/kg—or 1/100 the amount. Extrapolations from these results suggest that the anti-inflammatory compounds in Lyprinol are 200 times more potent than MaxEPA (and 350 times more potent than evening primrose oil).
Outperforms arthritis drugs without harmful side effects Researchers also compared the effectiveness of Lyprinol to that of the prescription arthritis drug indomethacin, the mainstream drug of choice at the time of the study. A dosage of 5 mg/kg of Lyprinol was 97 percent effective in reducing swelling, while indomethacin was only 83 percent effective at the same dosage.
Unlike indomethacin, Lyprinol is non-toxic and essentially free of side effects. In a 2000 study, researchers found that when compared to NSAIDs, three Lyprinol was “non-gastro toxic.”4 Recommendations for use Lyprinol is recommended for the alleviation of inflammatory conditions, including osteoarthritis, rheumatoid arthritis, and virally-induced arthritis. While Lyprinol appears to be the most powerful anti-inflammatory and arthritis pain reliever yet discovered, it still won’t rebuild or restore previously damaged cartilage. For the most complete healing of arthritis, we recommend you combine Lyprinol with a natural joint building supplement containing glucosamine and chondroitin. Recommended amounts: The amount needed for optimal results can vary widely for each individual, but range between two and four capsules per day. A higher amount (up to six capsules per day) can be used for the first one to two weeks of use. It can take up to four weeks to evaluate the full benefit. In addition, the research suggests that rubbing Lyprinol onto swollen and tender joints can help relieve pain and swelling. To do this, simply open the capsule and squeeze the contents onto the affected area.
See the Product Source Directory in the back of this report to learn how you can order Lyprinol.
Sources:
1 Practioner 1980; 224: 955-60
2 Gazette Medicale 1986; 93(38): 111-16
3 Inflammopharmacology 1997;5 : 237-46
4 Allergie et Immunologie 2000; 32(7): 272-78